Type 2 diabetes and the risks of cancer. The picture illustrates the association between diabetes and the risk of developing specific types of cancer, indicated by the presence of an upward arrow (↑) ...

Researchers from the University of California, Irvine, were the first to report an improvement in severe diabetes-related acute complications, such as dangerously low blood sugar that led to emergency ...

Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer. While glycemic control and weight management are ...

Dr Reddy’s Laboratories has received final approval from India’s drug regulator to launch a generic version of oral semaglutide, marking its entry in the fast‑growing GLP‑1 diabetes and obesity drug ...

Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D). Researchers at the Case Western Reserve School of Medicine have found that, when ...

GLP-1 medications for weight loss and diabetes appear to slow the body’s aging processes, a sign that the blockbuster drugs could ultimately help people live longer.

Henagliflozin, a popular drug prescribed for type 2 diabetes, has demonstrated potential anti-aging effects in a recent study published in Cell Reports Medicine. Telomeres are protective caps made of ...

Annemarije de Boer is a Los Angeles-based director and visual storyteller specializing in technology reviews and digital innovation journalism. Drawing from her BA in Psychology and decades of ...

While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes. At ...

Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of ...